University of Maryland Development Research Program
University of Maryland Development Research Program
批准号:
8233368
负责人:
Myron Max Levine
金额:
$40.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-03-01 至 2014-02-28
关键词:
AreaAwardCollaborationsComplementDataDetectionDevelopmentDiagnosticDiseaseEmerging Communicable DiseasesEmerging TechnologiesEnsureEventFundingGrantInfectious Diseases ResearchInstitutionLinkMarylandMethodologyMonitorProcessQualifyingResearchResearch PersonnelResearch Project GrantsResearch SupportReview CommitteeStrategic PlanningStructureSystemTestingToxinTrainingUniversitiesbiodefensehigh riskinnovationmeetingsnew technologynovelpathogenprogramsresearch and developmentsuccess
中文摘要
MARCE发展研究计划的主要目标是测试创新概念,
开发新技术,支持具有“高收益”潜力的“高风险”机会
在生物防御和新发传染病研究的广泛领域取得了新成果。所有申请者
对于这些奖项,预计将把他们的发展项目计划与总体主题
Marce,“新出现的病原体-宿主相互作用”,以及我们的一个研究计划。以年计
1,MARCE将征集五个发展研究奖的申请,金额为12万美元
每个项目为期2年,以支持诊断计划(VI)。将鼓励应用创新的项目
通过广谱平台检测方案中正在研究的制剂或毒素的技术
--V。在第三年,将征集专注于新兴技术的开发研究奖项目
和新的概念,并且可以集成到6个研究计划中的任何一个中。外部审查
委员会将协助申请审查过程。一个结构化的系统,用于监测和评估
选定项目的进展将确保该计划的成功。总体而言,发展研究
预计该计划将在几个方面加强和支持《马尔凯战略计划》。第一,加法
向MARCE提供新的调查人员和机构将补充现有的
Marce研究人员,并将为该领域注入新的想法和新的视角。第二,公司的成立
这些进入Marce的新项目将进一步扩大研究组合的范围。第三,
发展研究项目将通过以下方式加强现有研究方案之间的协同作用
作为连接方案项目主题的桥梁,并通过提供可能
适用于多个项目。最终,获得这些奖项的调查人员将增加总体
该领域的一批合格的研究人员。此外,这些奖项的获奖者将成为
Marce调查员网络,其思想交流和合作领域扩大
有可能在Marce会议和培训活动中进行直接互动。就像第一年的情况一样
在资助期内,将鼓励获奖者利用他们通过
由这些奖项支持的研究,以获得额外的竞争性赠款支持。以这种方式
最成功的研究项目和前景看好的新技术可以扩大和推广到
生物防御和新发传染病研究的效益。
英文摘要
The key objectives of the MARCE Developmental Research Plan are to test innovative concepts,
develop new technologies, and support "high-risk" opportunities that demonstrate potential for "highyield"
novel results in the broad area of biodefense and emerging infectious diseases research. All applicants
for theses Awards will be expected to relate their Developmental Project plans to the over-arching theme of
the MARCE, "Emerging pathogen-host interactions", as well as to one of our Research Programs. In year
1, the MARCE will solicit applications for five Developmental Research Awards in the amount of $120,000
each for 2 years to support the Diagnostics Program (VI). Projects will be encouraged that apply novel
technologies through broad-spectrum platforms for the detection of agents or toxins under study in Programs
-V. In year 3, Developmental Research Awards projects will be solicited that focus on emergent technologies
and novel concepts and that can integrate within any of the 6 Research Programs. An external review
committee will assist in the application review process. A structured system to monitor and evaluate the
progress of the selected projects will ensure the success of the Plan. Overall, the Developmental Research
Plan is anticipated to enhance and support the MARCE Strategic Plan in several ways. First, the addition
of new investigators and institutions to MARCE will complement the existing interactions among established
MARCE researchers and will inject fresh ideas and new perspectives into the field. Second, the incorporation
of these new projects into MARCE will further expand the scope of the research portfolio. Third, the
Developmental Research Projects will enhance synergies within the existing Research Programs by
serving as bridges to link programmatic project themes and by providing new methodologies that may be
applicable to several projects. Ultimately, the investigators who receive these Awards will increase the overall
pool of qualified researchers in this field. In addition, the recipients of these Awards will become part of the
network of MARCE investigators whose exchange of ideas and expanded areas of collaboration are made
possible via direct interaction at MARCE meetings and training events. As was the case during the first
funding period, recipients will be encouraged to exploit the preliminary data that they generated through
research supported by these Awards into the acquisition of additional competitive grant support. In this way
the most successful research projects and promising new technologies can be amplified and extended for the
benefit of biodefense and emerging infectious disease research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
-
批准号:9893801
-
项目类别:
-
资助金额:$250.0万
-
财政年份:2019
-
负责人:Myron Max Levine
-
依托单位:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
-
批准号:10584474
-
项目类别:
-
资助金额:$250.0万
-
财政年份:2019
-
负责人:Myron Max Levine
-
依托单位:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
-
批准号:10364708
-
项目类别:
-
资助金额:$250.0万
-
财政年份:2019
-
负责人:Myron Max Levine
-
依托单位:
Administrative Core
-
批准号:10364709
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2019
-
负责人:Myron Max Levine
-
依托单位:
Administrative Core
-
批准号:10584475
-
项目类别:
-
资助金额:$21.11万
-
财政年份:2019
-
负责人:Myron Max Levine
-
依托单位:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
-
批准号:9232995
-
项目类别:
-
资助金额:$531.26万
-
财政年份:2014
-
负责人:Myron Max Levine
-
依托单位:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
-
批准号:9447098
-
项目类别:
-
资助金额:$497.35万
-
财政年份:2014
-
负责人:Myron Max Levine
-
依托单位:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
-
批准号:8642251
-
项目类别:
-
资助金额:$489.44万
-
财政年份:2014
-
负责人:Myron Max Levine
-
依托单位:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
-
批准号:8803292
-
项目类别:
-
资助金额:$495.03万
-
财政年份:2014
-
负责人:Myron Max Levine
-
依托单位:
Administrative Core
-
批准号:8233367
-
项目类别:
-
资助金额:$68.94万
-
财政年份:2011
-
负责人:Myron Max Levine
-
依托单位:
Vaccine strategy for broad spectrum protection agains non-typhoidal salmonell
-
批准号:8233360
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2011
-
负责人:Myron Max Levine
-
依托单位:
Phase I trial of two candidate live oral salmonella enterica serovar paratyphi A
-
批准号:8332525
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2011
-
负责人:Myron Max Levine
-
依托单位:
Vaccine strategy for broad spectrum protection agains non-typhoidal salmonell
-
批准号:7669835
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2009
-
负责人:Myron Max Levine
-
依托单位:
Administrative Core
-
批准号:7669991
-
项目类别:
-
资助金额:$61.28万
-
财政年份:2009
-
负责人:Myron Max Levine
-
依托单位:
Middle Atlantic Regional Center for Excellence for Biodefense and Emerging Infect
-
批准号:7903542
-
项目类别:
-
资助金额:$66.98万
-
财政年份:2009
-
负责人:Myron Max Levine
-
依托单位:
Phase I trial of two candidate live oral salmonella enterica serovar paratyphi A
-
批准号:7669838
-
项目类别:
-
资助金额:$38.87万
-
财政年份:2009
-
负责人:Myron Max Levine
-
依托单位:
University of Maryland Development Research Program
-
批准号:7670014
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2009
-
负责人:Myron Max Levine
-
依托单位:
Administrative Core
-
批准号:7678839
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2008
-
负责人:Myron Max Levine
-
依托单位:
New Opportunities - Heterologous Prime-boost Product Development Project
-
批准号:7680585
-
项目类别:
-
资助金额:$17.02万
-
财政年份:2008
-
负责人:Myron Max Levine
-
依托单位:
Middle Atlantic Regional Center for Excellence for Biodefense and Emerging Infect
-
批准号:8442349
-
项目类别:
-
资助金额:$682.3万
-
财政年份:2003
-
负责人:Myron Max Levine
-
依托单位:
海外基金